Physician profile
Tori L Odaniel
NPI 1073845640
$917,345.16
in general payments reported to CMS, 2019-2025
7 companies · $321K in 2025
The $321K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $10K · 2021: $670 · 2022: $71K · 2023: $226K · 2024: $269K · 2025: $321K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $477K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $212K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $55K · Travel and Lodging: $37K · Honoraria: $32K · Food and Beverage: $4,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $477,117.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $211,900.62 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $54,709.90 |
| Travel and Lodging | $36,507.52 |
| Honoraria | $32,163.50 |
| Food and Beverage | $4,109.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $776,157.83 | 2021-2025 | Kiwi Procup |
| Organon LLC | $100,200.87 | 2022-2025 | Jada System, Hadlima |
| Clinical Innovations, LLC | $29,448.63 | 2019-2021 | |
| Gen-Probe, INC. | $11,127.27 | 2022-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Gen-Probe Sales & Service, INC. | $241.73 | 2022 | |
| Alydia Health | $88.11 | 2021 | |
| Hologic Sales and Service, LLC | $80.72 | 2025 | Fetal Fibronectin Enzyme Immunoassay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tori Odaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.